Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of 5% and 10% trisodium citrate versus heparin as catheter-locking solutions for central venous hemodialysis catheters
TCTR20170314002Enrolling by invitation
- Sponsor
- Pattharawin Pattharanitima
- Start
- Jun 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of trisodium citrate and heparin in end-stage kidney disease (ESKD), sponsored by Pattharawin Pattharanitima. Started Jun 2016; status: enrolling by invitation.
02
Drugs
trisodium citrateheparin
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on TCTR20170314002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170314002.